ANG II- and TxA2-induced mesenteric vasoconstriction in rats is mediated by separate cell signaling pathways
Physiologisches Institut and Universitäts-Kinderklinik, Ruprecht-Karls-Universität Heidelberg, D-69120 Heidelberg, Germany; and Department of Internal Medicine, University of Udine, I-33100 Udine, Italy Studies in vitro have demonstrated that vasoconstrictor agents increase intracellular Ca 2+ and a...
Gespeichert in:
Veröffentlicht in: | American journal of physiology. Heart and circulatory physiology 1999-07, Vol.277 (1), p.H1 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Physiologisches Institut and Universitäts-Kinderklinik,
Ruprecht-Karls-Universität Heidelberg, D-69120 Heidelberg,
Germany; and Department of Internal Medicine, University of Udine,
I-33100 Udine, Italy
Studies in vitro have demonstrated that vasoconstrictor agents
increase intracellular Ca 2+ and
activate protein kinase C (PKC) to elevate vascular tone. The aim of
the present study was to determine the importance of these signaling
pathways for angiotensin II (ANG II) and thromboxane A 2
(TxA 2 ) in regulating mesenteric
blood flow (MBF) in vivo. In anesthetized rats increasing doses of ANG
II or the TxA 2 agonist U-46619
were administered into the superior mesenteric artery to reduce MBF.
Intra-arterial infusion of inhibitors served to examine the
contribution of different pathways: 8-(diethylamino)octyl 3,4,5-trimethoxybenoate hydrochloride (TMB-8) to inhibit intracellular Ca 2+ release, nifedipine to block
transmembrane Ca 2+ influx through
the L-type Ca 2+ channel, and
staurosporine to inhibit PKC. Each of the inhibitors attenuated ANG
II-induced reductions in MBF, and all dose-response curves were shifted
to the right to an approximately threefold higher ANG II dose.
Combinations of the inhibitors revealed that their effects were
additive; together they abolished the vasoconstrictor action of ANG II
completely. In contrast, the dose-response curve for U-46619 was not
affected by any of the inhibitors infused either separately or
together. The results demonstrate that a rise in intracellular
Ca 2+ and activation of PKC are
major mediators of the vasoconstrictor effect of ANG II in mesenteric
circulation, but they play a subordinate role, if any, for the effects
of TxA 2 . Because
TxA 2 plays a major role only under
pathological conditions, the uncontrolled vasoconstriction appears to
be associated with the recruitment of novel signal transduction pathways.
protein kinase C; L-type calcium channels; U-46619; mesenteric
blood flow; sensitization |
---|---|
ISSN: | 0363-6135 1522-1539 |
DOI: | 10.1152/ajpheart.1999.277.1.h1 |